New hope for late-stage breast cancer patients with no other options
Disease control
Recruiting now
This study tests whether a new treatment called Bria-IMT, given with an immunotherapy drug, helps people with advanced metastatic breast cancer live longer compared to standard chemotherapy. About 404 adults whose cancer has not responded to other treatments will participate. The…
Phase: PHASE3 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC